Market Cap : 1.7 B | Enterprise Value : 1.54 B | PE Ratio : | PB Ratio : 18.66 |
---|
NAS:IMGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IMGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Immunogen's other operating expense for the three months ended in Sep. 2020 was $0.0 Mil. Its other operating expense for the trailing twelve months (TTM) ended in Sep. 2020 was $-0.0 Mil.
Immunogen's quarterly other operating expense increased from Mar. 2020 ($-0.0 Mil) to Jun. 2020 ($0.0 Mil) but then stayed the same from Jun. 2020 ($0.0 Mil) to Sep. 2020 ($0.0 Mil).
Immunogen's annual other operating expense declined from Dec. 2017 ($0.0 Mil) to Dec. 2018 ($-0.0 Mil) but then increased from Dec. 2018 ($-0.0 Mil) to Dec. 2019 ($0.0 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expenses" section.
Other operating expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of other operating expenses which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2020 was 0 (Dec. 2019 ) + -1.7763568394003E-15 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) = $-0.0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline